(Q52887889)

9 May 2018

title

[Comments on the pathogenesis of Behçet's disease. A key to understanding new therapies?]. (English)

1 reference

9 May 2018

0 references

U Pleyer

1

1 reference

9 May 2018

D Hazirolan

series ordinal

2

1 reference

9 May 2018

N Stübiger

series ordinal

3

1 reference

9 May 2018

language of work or name

German

0 references

publication date

1 June 2012

1 reference

9 May 2018

published in

Ophthalmologe

1 reference

9 May 2018

volume

109

1 reference

9 May 2018

issue

6

1 reference

9 May 2018

page(s)

563-567

1 reference

9 May 2018

https://scigraph.springernature.com/pub.10.1007/s00347-012-2586-z

exact match

0 references

cites work

Successful treatment of acute visual loss in Muckle-Wells syndrome with interleukin 1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2586-Z

TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2586-Z

Comparison of serum nitric oxide, malondialdehyde levels, and antioxidant enzyme activities in Behçet's disease with and without ocular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2586-Z

Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2586-Z

Resistant Behçet disease responsive to anakinra

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2586-Z

Immunological and inflammatory functions of the interleukin-1 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2586-Z

Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2586-Z

Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2586-Z

Interleukin-1 cytokines, inflammasomes, NOD-signalosomes and autoinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2586-Z

Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2586-Z

The spectrum of monogenic autoinflammatory syndromes: understanding disease mechanisms and use of targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2586-Z

Interleukin-1-receptor antagonist in the Muckle-Wells syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2586-Z

Abnormal T cell responses to bacterial superantigens in Behçet's disease (BD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2586-Z

Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2586-Z

Cryopyrin activates the inflammasome in response to toxins and ATP

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2586-Z

The inflammasomes: guardians of the body

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2586-Z

Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2586-Z

Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2586-Z

HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2586-Z

HLA typing in uveitis: use and misuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2586-Z

Serum substance P and calcitonin gene-related peptide levels in Behçet's disease and their association with disease activity

21 January 2018

1 reference

12 December 2020

The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behçet's disease. A randomized clinical trial

1 reference

12 December 2020

[The HLA pattern in Adamantiades-Behçet's disease in Germany. Association of occurrence, clinical symptoms and follow-up in 39 patients]

1 reference

12 December 2020

Chemokine expression of intraocular lymphocytes in patients with Behçet uveitis

1 reference

12 December 2020

Serum interleukin-8 as a serologic marker of activity in Behçet's disease

1 reference

12 December 2020

Circulating soluble CD28 in patients with Behçet's disease: relationship to clinical manifestations

1 reference

12 December 2020

Synovial fluid cytokine levels in Behçet's disease

1 reference

12 December 2020

Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336-351

1 reference

12 December 2020

Phenotypic characteristics of B cells in Behçet's disease: increased activity in B cell subsets

1 reference

12 December 2020

Lack of association of HLA-B*51 with a severe disease course in Behçet's disease

1 reference

12 December 2020

10.1007/S00347-012-2586-Z

Identifiers

DOI

1 reference

9 May 2018

PubMed ID

22699947

1 reference

9 May 2018